Analytical Rigour.
Reproducible Results.
Our research programme covers alkaloid profiling, extraction optimisation, stability studies and bioactivity assessment — all conducted or verified by accredited independent laboratories across Europe.
How We Verify Every Batch
A six-stage quality pipeline ensures that every product leaving our facility has been independently verified for identity, purity, potency and absence of contaminants.
Plant Identification
Morphological and molecular verification of T. iboga versus related species before processing begins.
Extraction & Fractionation
Standardised ethanol extraction followed by acid-base partition to isolate total alkaloid fraction.
HPLC-DAD Analysis
High-performance liquid chromatography with diode-array detection quantifies ibogaine, noribogaine, tabernanthine and 12 minor alkaloids.
Heavy Metals Screening
ICP-MS analysis for lead, mercury, cadmium and arsenic against European Pharmacopoeia limits.
Microbial Testing
Total aerobic count, yeast/mould, E. coli and Salmonella tested per EP 2.6.12 criteria.
Certificate of Analysis
Full CoA issued by accredited ISO 17025 laboratory. Downloadable from each product page.
Current Focus Areas
Our research collaborations with European universities and independent institutes address both fundamental phytochemistry and applied pharmacology.
Alkaloid Profiling
Comprehensive mapping of the 17 known iboga alkaloids across different chemotypes, harvest regions and processing methods. Building the most extensive ibogaine congener database in Europe.
Extraction Optimisation
Systematic evaluation of solvent systems, temperature gradients and filtration protocols to maximise alkaloid yield while minimising co-extracted impurities.
Stability Studies
ICH Q1A-compliant accelerated and long-term stability testing to establish shelf life and appropriate storage conditions for each product format.
Bioactivity Assessment
Collaboration with two European pharmacology institutes to characterise receptor-binding profiles and in-vitro cytotoxicity thresholds for primary alkaloid fractions.
Ethnobotanical Mapping
Fieldwork in Gabon and Cameroon documenting traditional preparation methods, dosage knowledge and ceremonial contexts — preserving cultural IP alongside scientific data.
Regulatory Dossier Development
Building EU Article 16(d) traditional-use dossiers to support future registration pathways for standardised iboga preparations.
Selected Research Outputs
Peer-reviewed publications, conference proceedings and internal technical reports available to registered researchers.
Independent Verification Network
We do not rely on in-house testing alone. Every product is verified by at least one ISO 17025-accredited laboratory from our independent partner network.
Netherlands
ISO 17025-accredited analytical laboratory. Primary partner for HPLC-DAD and ICP-MS analysis.
Switzerland
Specialised in pharmacopoeial identity testing and European Pharmacopoeia compliance verification.
Germany
Microbial testing and mycotoxin screening. COFRAC-equivalent DAkkS accreditation.
France
Bioactivity and receptor-binding studies conducted in partnership with a Lyon pharmacology institute.
Request Analytical Documentation
CoAs, stability reports and methodology summaries are available to registered researchers and licensed practitioners.